Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 424.00
+1.50 (0.36%)
Sep 30, 2026, 1:30 PM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 53.78 billion as of September 29, 2026. Its market cap has decreased by -36.28% in one year.
Market Cap
53.78B
Enterprise Value
69.52B
Revenue
19.56B
Ranking
n/a
PE Ratio
45.47
Stock Price
424.00
ChartMarket Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 53.78B, an increase of 1,600.86%. That is a compound annual growth rate of 26.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 53.78B | -11.14% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 47.33B |
| Center Laboratories | 24.48B |
| Handa Pharmaceuticals | 20.15B |
| TTY Biopharm Company | 19.47B |
| Synmosa Biopharma | 15.91B |
| YungShin Global Holding | 14.92B |
| ScinoPharm Taiwan | 14.71B |
| Grape King Bio | 12.89B |